Company profile
UK company 10028228, incorporated on 26 February 2016.
Omass Therapeutics Limited is a UK company with status Active founded in 2016 based in South East England.
Company number 10028228
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Mass spectrometry techniques for biotherapeutics/membrane proteins
OMass is an Oxford University spin-out company applying MS technology to drug discovery. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulation of complex formation, with both effects, binding and function, being measured by a change in mass.
Interest and contracts from industry / interest from investors
The methods developed by OMass are being applied to drug discovery for a variety of complex targets, including membrane receptors.
1 Mar 2018 to 31 May 2021
Membrane proteins represent the largest class of drug targets. Developing new ways to study these targets is therefore of paramount importance in drug development programmes. This project addresses this need by developing and applying novel technology to understand drug binding to membrane proteins in the most natural environment possible. Our innovation ...
